Cancer Detection and Diagnosis Research in New York
Cancer Detection and Diagnosis Research (93.394) awarded $238 million to recipients in New York in 168 grants from fiscal 2021 to 2025, 8.8% of the program's national total. Sloan-Kettering Institute for Cancer Research received the most, $88.7 million.
- Awarded in New York$238 million
- Awards168
- Share of the program8.8%
- Rank among states2nd of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 92 | $50.3 million |
| FY 2022 | 95 | $48.4 million |
| FY 2023 | 92 | $49.0 million |
| FY 2024 | 83 | $44.0 million |
| FY 2025 | 73 | $46.7 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Sloan-Kettering Institute for Cancer Research | Nonprofits | 52 | $88.7 million |
| New York University | Colleges and universities | 21 | $29.9 million |
| Weill Medical College of Cornell University | Colleges and universities | 16 | $23.1 million |
| Icahn School of Medicine at Mount Sinai | Colleges and universities | 11 | $21.0 million |
| The Trustees of Columbia University in the City of New York | Colleges and universities | 10 | $16.5 million |
| Albert Einstein College of Medicine | Colleges and universities | 8 | $7.6 million |
| The Research Foundation for the State University of New York | Other | 5 | $6.9 million |
| Health Research, Inc. | Nonprofits | 6 | $6.1 million |
| Rensselaer Polytechnic Institute | Colleges and universities | 3 | $4.5 million |
| Research Foundation of the City University of New York | Nonprofits | 1 | $3.3 million |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to New York?
$238 million from fiscal 2021 to 2025, across 168 awards. New York ranks 2nd of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in New York?
The largest recipient is Sloan-Kettering Institute for Cancer Research, with $88.7 million in 52 awards. Next are New York University and Weill Medical College of Cornell University.
Can organizations in New York apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund